30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Interventional Spine Announces FDA Clearance of Lordotic Opticage™ -

Interventional Spine, Inc. announced FDA clearance of the 80 Lumbar Lordotic Opticage™ Expandable Intervertebral Body Fusion Device, indicated for use with autogenous bone graft in patients with degenerative disc disease at one or two contiguous levels from L2-S1. 

This device joins the Interventional Spine family of Opticage™ Expandable Interbody Fusion implants cleared in 4Q15, and can also be used with the company's PerX360 System™.

Opticage can be implanted via posterior, transforaminal or lateral approach.

Source: Interventional Spine, Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.